We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
-15.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
-$79.4M
Cap. Flow
-$91M
Cap. Flow %
-43.93%
Top 10 Hldgs %
21.97%
Holding
890
New
197
Increased
94
Reduced
202
Closed
375

Sector Composition

Rank Sector Weight
1 Healthcare 17.98%
2 Technology 16.3%
3 Consumer Discretionary 16.11%
4 Consumer Staples 11.7%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
26
Sherwin-Williams
SHW
$83.8B
$3.24M 1.57%
+34,206
New +$3.19M
BBWI icon
27
Bath & Body Works
BBWI
$3.76B
$3.24M 1.56%
+42,469
New +$3.07M
KDP icon
28
Keurig Dr Pepper
KDP
$43.4B
$3.22M 1.55%
41,020
-3,169
-7% -$245K
CELG
29
DELISTED
Celgene Corp
CELG
$3.21M 1.55%
+27,863
New +$3.33M
WHR icon
30
Whirlpool
WHR
$2.59B
$3.21M 1.55%
15,866
+14,753
+1,326% +$3M
ALKS icon
31
Alkermes
ALKS
$8.21B
$2.77M 1.34%
45,465
+45,269
+23,096% +$3.09M
DISH
32
DELISTED
DISH Network Corp.
DISH
$2.39M 1.15%
34,127
-1,517
-4% -$112K
CAH icon
33
Cardinal Health
CAH
$54.7B
$2.21M 1.06%
24,434
+7,334
+43% +$631K
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$1.77M 0.85%
8,568
+7,913
+1,208% +$1.63M
PNC icon
35
PNC Financial Services
PNC
$97.1B
$1.73M 0.84%
18,593
+2,820
+18% +$255K
ABBV icon
36
AbbVie
ABBV
$456B
$1.72M 0.83%
29,375
+4,361
+17% +$263K
VZ icon
37
Verizon
VZ
$205B
$1.61M 0.78%
33,152
-15,408
-32% -$744K
BLK icon
38
Blackrock
BLK
$181B
$1.49M 0.72%
4,078
-1,529
-27% -$554K
AMGN icon
39
Amgen
AMGN
$236B
$1.48M 0.71%
9,255
+1,706
+23% +$269K
GE icon
40
GE Aerospace
GE
$355B
$1.43M 0.69%
12,028
-20,161
-63% -$2.4M
CVX icon
41
Chevron
CVX
$392B
$1.42M 0.68%
13,516
+26
+0.2% +$2.77K
INTC icon
42
Intel
INTC
$487B
$1.42M 0.68%
45,357
-34,828
-43% -$1.18M
PFE icon
43
Pfizer
PFE
$160B
$1.41M 0.68%
42,844
-5,735
-12% -$182K
MSFT icon
44
Microsoft
MSFT
$3.75T
$1.36M 0.66%
33,509
+9,088
+37% +$396K
JCI icon
45
Johnson Controls International
JCI
$86.1B
$1.3M 0.63%
24,617
+5,651
+30% +$287K
CSCO icon
46
Cisco
CSCO
$442B
$1.26M 0.61%
45,956
-1,941
-4% -$54.6K
INCY icon
47
Incyte
INCY
$25.9B
$1.26M 0.61%
13,800
-438
-3% -$36.2K
ITW icon
48
Illinois Tool Works
ITW
$80.2B
$1.26M 0.61%
12,995
+867
+7% +$83.6K
VFC icon
49
VF Corp
VFC
$5.36B
$1.25M 0.6%
17,653
+5,227
+42% +$362K
KO icon
50
Coca-Cola
KO
$383B
$1.24M 0.6%
30,678
+1,880
+7% +$78.6K

Similar funds

Crosspoint Capital Strategies's Q1 2015 Portfolio in Review

As of Q1 2015, Crosspoint Capital Strategies held 890 positions worth $207M, down 28% from $287M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Crosspoint Capital Strategies withdrew a net $91M in Q1 2015, closing 375 positions and reducing 202 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Crosspoint Capital Strategies opened a new position in Dorchester Minerals worth $4.64M.

  • Crosspoint Capital Strategies's largest Q1 2015 buy was Dorchester Minerals: 204,210 shares worth $4.64M.
  • Crosspoint Capital Strategies added most to Ambarella in Q1 2015, an estimated $3.51M increase.
  • Crosspoint Capital Strategies's biggest Q1 2015 reduction was Berkshire Hathaway Class B, cutting an estimated $7.89M.
  • Crosspoint Capital Strategies fully exited Agios Pharmaceuticals in Q1 2015, selling an estimated $4.46M.
  • Crosspoint Capital Strategies's ten largest holdings make up 22% of its $207M portfolio in Q1 2015.
  • Crosspoint Capital Strategies opened 197 new positions and closed 375 in Q1 2015.
  • Crosspoint Capital Strategies's portfolio value fell 28% quarter-over-quarter to $207M.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2015, filed 18 May 2015.